COPD immunopathology

Gaetano Caramori, Paolo Casolari, Adam Barczyk, Andrew L. Durham, Antonino Di Stefano, Ian Adcock

Research output: Contribution to journalReview article

Abstract

The immunopathology of chronic obstructive pulmonary disease (COPD) is based on the innate and adaptive inflammatory immune responses to the chronic inhalation of cigarette smoking. In the last quarter of the century, the analysis of specimens obtained from the lower airways of COPD patients compared with those from a control group of age-matched smokers with normal lung function has provided novel insights on the potential pathogenetic role of the different cells of the innate and acquired immune responses and their pro/anti-inflammatory mediators and intracellular signalling pathways, contributing to a better knowledge of the immunopathology of COPD both during its stable phase and during its exacerbations. This also has provided a scientific rationale for new drugs discovery and targeting to the lower airways. This review summarises and discusses the immunopathology of COPD patients, of different severity, compared with control smokers with normal lung function.

Original languageEnglish
Pages (from-to)1-19
Number of pages19
JournalSeminars in Immunopathology
DOIs
Publication statusPublished - May 13 2016

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'COPD immunopathology'. Together they form a unique fingerprint.

  • Cite this

    Caramori, G., Casolari, P., Barczyk, A., Durham, A. L., Di Stefano, A., & Adcock, I. (2016). COPD immunopathology. Seminars in Immunopathology, 1-19. https://doi.org/10.1007/s00281-016-0561-5